Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Direct serum assay for cell-free bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer.
Levels of Bmi-1 mRNA were increased in colorectal cancer serum samples.
»
12/29/14
Expression of Semaphorin 3C in Breast Cancer and its Impact on Adhesion and Invasion of Breast Cancer Cells.
Higher SEMA3C expression is correlated with tumour differentiation.
»
03/16/16
Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
Both LKB1 mRNA and protein expression in gastric cancer were independent prognostic factors for OS.
»
03/16/16
The EGF receptor promotes the malignant potential of glioma by regulating amino acid transport system xc(-).
Targeted inhibition of xCT suppressed the EGFR-dependent enhancement of antioxidant capacity in glioma cells.
»
03/17/16
Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis.
CCK8 assay showed that CCAT2 knockdown inhibited cell proliferation in HeLa cells.
»
03/18/16
TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells Through NF-κB Signaling.
Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-κB.
»
10/09/15
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
Intratumoral drug levels were negatively related to intrinsic and acquired resistance to docetaxel.
»
11/26/15
Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass.
The new R-OPS scoring system showed good discrimination between non-cancerous lesions and OC.
»
12/17/15
Cost-effectiveness analysis of papillary thyroid cancer surveillance.
The cost to detect a recurrence in a low-risk patient is more than 6 and 7 times greater than the cost for intermediate- and high-risk PTC patients.
»
05/27/15
Molecular backgrounds of ERAP1 downregulation in cervical carcinoma.
Loss of heterozygosity was demonstrated to occur in up to 50% of tumors with ERAP1 downregulation.
»
03/16/15
< Prev
Next >